Anubis Barcelona Regul Oil
- Product NDC
- 83021-300
- 11-digit product format
- 830210300
- Labeler code
- 83021
- Product ID
- 83021-300_0452aac5-a076-8ea7-e063-6394a90a7c02
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Propylene Glycol, Glyceryl Stearate Se, Humulus Lupulus (Hops) Cone Extract
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- ANUBIS COSMETICS SL
- Application
- M006
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-10-20
- Marketing end
- 2028-02-03
- Substance
- ARCTIUM LAPPA ROOT; POLYACRYLAMIDE (CROSSLINKED; 0.01-0.2 MOLE PERCENT BISACRYLAMIDE); LAURETH-7; PEG/PPG-20/6 DIMETHICONE; ALCOHOL; GLYCERIN; CETEARYL ETHYLHEXANOATE; LIMONENE, (+)-; PANTHENOL; IMIDUREA; FD&C YELLOW NO. 5; RIBOFLAVIN; PHENOXYETHANOL; FRAGRANCE 13576; WATER; CETOSTEARYL ALCOHOL; PROPYLENE GLYCOL; MINERAL OIL; ETHYLHEXYLGLYCERIN; METHYLCHLOROISOTHIAZOLINONE; METHYLISOTHIAZOLINONE; HOPS; TIOXOLONE; PROPYLPARABEN; YEAST, UNSPECIFIED; NIACINAMIDE; C13-14 ISOPARAFFIN; METHYLPARABEN; GLYCERYL STEARATE SE; TRIISOPROPANOLAMINE; PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE)
- Active strength
- .012; .8; .12; 1.372; .08; .048; 4; .08398; .1; .6; .00004; .00012; .0252; .6; 123.55598; 26; 10.148; 6; .0028; .045; .15; .0012; .3; .24; .023; .023; .48; .48; 7; .004; .0012 g/200mL; g/200mL; g/200mL; g/200mL; mL/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; mL/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL
- Pharmacologic classes
- Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anubis Barcelona Regul Oil
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ARCTIUM LAPPA ROOT | .012 g/200mL |
| POLYACRYLAMIDE (CROSSLINKED | .8 g/200mL |
| 0.01-0.2 MOLE PERCENT BISACRYLAMIDE) | .12 g/200mL |
| LAURETH-7 | 1.372 g/200mL |
| PEG/PPG-20/6 DIMETHICONE | .08 mL/200mL |
| ALCOHOL | .048 g/200mL |
| GLYCERIN | 4 g/200mL |
| CETEARYL ETHYLHEXANOATE | .08398 g/200mL |
| LIMONENE, (+)- | .1 g/200mL |
| PANTHENOL | .6 g/200mL |
| IMIDUREA | .00004 g/200mL |
| FD&C YELLOW NO. 5 | .00012 g/200mL |
| RIBOFLAVIN | .0252 g/200mL |
| PHENOXYETHANOL | .6 g/200mL |
| FRAGRANCE 13576 | 123.55598 mL/200mL |
| WATER | 26 g/200mL |
| CETOSTEARYL ALCOHOL | 10.148 g/200mL |
| PROPYLENE GLYCOL | 6 g/200mL |
| MINERAL OIL | .0028 g/200mL |
| ETHYLHEXYLGLYCERIN | .045 g/200mL |
| METHYLCHLOROISOTHIAZOLINONE | .15 g/200mL |
| METHYLISOTHIAZOLINONE | .0012 g/200mL |
| HOPS | .3 g/200mL |
| TIOXOLONE | .24 g/200mL |
| PROPYLPARABEN | .023 g/200mL |
| YEAST, UNSPECIFIED | .023 g/200mL |
| NIACINAMIDE | .48 g/200mL |
| C13-14 ISOPARAFFIN | .48 g/200mL |
| METHYLPARABEN | 7 g/200mL |
| GLYCERYL STEARATE SE | .004 g/200mL |
| TRIISOPROPANOLAMINE | .0012 g/200mL |
| PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 597E9BI3Z3 | Internal UNII lookup |
| Z95S6G8201 | Internal UNII lookup |
| PWZ7N4UIKE | Internal UNII lookup |
| 3K9958V90M | Internal UNII lookup |
| PDC6A3C0OX | Internal UNII lookup |
| 9M64UO4C25 | Internal UNII lookup |
| GFD7C86Q1W | Internal UNII lookup |
| WV9CM0O67Z | Internal UNII lookup |
| M629807ATL | Internal UNII lookup |
| I753WB2F1M | Internal UNII lookup |
| TLM2976OFR | Internal UNII lookup |
| HIE492ZZ3T | Internal UNII lookup |
| 5EM498GW35 | Internal UNII lookup |
| 059QF0KO0R | Internal UNII lookup |
| 2DMT128M1S | Internal UNII lookup |
| 6DC9Q167V3 | Internal UNII lookup |
| T5L8T28FGP | Internal UNII lookup |
| 147D247K3P | Internal UNII lookup |
| DEL7T5QRPN | Internal UNII lookup |
| 229D0E1QFA | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| eb7c418b-8bee-26a3-e053-2a95a90a4e96 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cf050ccd-1144-f76a-e00d-e5698d8597d4 | Product name | 6 | 20250625 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83021-300-01 | Anubis Barcelona Regul Oil | 200 mL in 1 TUBE | CREAM | 200 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83021-300 | ANUBIS BARCELONA REGUL OIL (PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT) CREAM [ANUBIS COSMETICS SL] | 2 | Current NDC, Legacy NDC, 1 package rows | 20230902_eb7c418b-8bee-26a3-e053-2a95a90a4e96.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dermaharmony 10% Sulfur | SULFUR | D3 Development, Inc. | c78ead80-a8ee-0b52-e053-2a95a90ab880 | 2025-12-01 | Warnings | M006 |
| Dermaharmony 10% Sulfur with Tea Tree Oil | SULFUR | D3 Development, Inc. | c79005d4-0c6f-75d0-e053-2995a90a8314 | 2025-12-01 | Warnings | M006 |
| Resurfacing acne swipes | SALICYLIC ACID | Oars And Alps LLC | efe14f46-c947-aea4-e053-2a95a90aad5f | 2025-12-01 | Warnings | M006 |
| EradiKate ACNE TREATMENT | SULFUR | Rare Beauty Brands Inc | 44ebacf3-52c1-4896-e063-6394a90ac447 | 2025-12-01 | Warnings | M006 |
| EradiKate Daily Foaming Cleanser Acne Treatment | SULFUR | Rare Beauty Brands Inc. | 44ebc725-796f-71e6-e063-6294a90a69a6 | 2025-12-01 | Warnings | M006 |
| ERADIKATE ACNE MARK FADING | SALICYLIC ACID | Rare Beauty Brands Inc. | 44ebe505-1ce8-88cf-e063-6394a90a4baf | 2025-12-01 | Warnings | M006 |
| Jane Seymour Natural Advantage AM SPF 15 All Day Moisture with AHAs | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | Guthy-Renker,LLC | 76298090-e873-4307-8bdb-19cdab6d9ac2 | 2025-12-01 | Warnings | M006 |
| Asepxia Baking Soda Acne Bar | SALICYLIC ACID | Genomma Lab USA | ded9fe59-9477-4425-8bbb-f9a49118f004 | 2025-12-01 | Warnings | M006 |
| Blemish Buster Solution Acne Treatment | SULFUR | Guthy-Renker LLC | d2b9462d-7897-40a4-9022-eeb04e7d5adf | 2025-12-01 | Warnings | M006 |
| Anna Guanche MD Miracle Cream The Pimple Cream | SULFUR | Bella Cosmeceuticals, Inc. | b4562cf4-aae3-e9db-e053-2995a90a7210 | 2025-11-30 | Warnings | M006 |
| Vanishing Skincare | VANISHING DRY SERUM MASK, PHASE 3 | Vanish Skincare LLC | 27f19c03-1a18-6c74-e063-6394a90a6e86 | 2025-11-28 | Warnings | M006 |
| OUHOE CLEARFACE Overnight Acne | SALICYLIC ACID | Shantou Ouhoe Technology Co., Ltd. | 2be1e888-e0a4-7db7-e063-6294a90a77d5 | 2025-11-27 | Warnings | M006 |
| EELHOE Acne | SALICYLIC ACID | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 2a88a374-64bc-02a3-e063-6294a90a333e | 2025-11-27 | Warnings | M006 |
| EELHOE Mole Reduce Essence | SALICYLIC ACID | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 2f80ffc4-c945-71c9-e063-6394a90add8c | 2025-11-27 | Warnings | M006 |
| JAYSUING ACNE PATCHES | SALICYLIC ACID | Shantou Jaysuing Cleaning and Environmental Protection Technology Co., Ltd. | 29fb7bcc-a630-1fba-e063-6294a90a65c1 | 2025-11-27 | Warnings | M006 |
| Relief | COLLOIDAL OATMEAL 1% | Era Organics, Inc. | 0ad58a99-e41a-a830-e063-6294a90af9cb | 2025-11-27 | Warnings | M006 |
| Superbalm | COLLOIDAL OATMEAL 1% | Era Organics, Inc. | f5298e5e-583d-d74c-e053-2995a90affb5 | 2025-11-27 | Warnings | M006 |
| OGEE CLEARGANICS TARGETED BLEMISH TREATMENT | SALICYLIC ACID ACNE MEDICATION | Ogee Inc | 162831d3-7e95-62f4-e063-6394a90aef7c | 2025-11-26 | Warnings | M006 |
| EELHOE Pimple Patches | SALICYLIC ACID | Shantou Ximonth Biotechnology Co., Ltd. | ffd4972a-f9bd-44a4-9d29-cd5722696805 | 2025-11-26 | Warnings | M006 |
| OUHOE PIMPLE | SALICYLIC ACID | Shantou Woodsleep Biotechnology Co., Ltd. | 2a374e1c-0d21-e16c-e063-6394a90ab487 | 2025-11-26 | Warnings | M006 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 83021-300-01 | 83021030001 | 200 mL in 1 TUBE (83021-300-01) | 200 ml | 2022-10-20 | 2028-02-03 | No | No | Current |